rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2002-2-13
|
pubmed:abstractText |
Millions of women worldwide use depot medroxyprogesterone acetate (DMPA) for contraception. Common side effects include bleeding irregularities and weight gain. This study examines whether a relation exists between DMPA use in obese and overweight women and increased uterine bleeding.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0893-8652
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7-10
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:11841143-Adolescent,
pubmed-meshheading:11841143-Adult,
pubmed-meshheading:11841143-Body Mass Index,
pubmed-meshheading:11841143-Contraceptive Agents, Female,
pubmed-meshheading:11841143-Female,
pubmed-meshheading:11841143-Humans,
pubmed-meshheading:11841143-Medical Records,
pubmed-meshheading:11841143-Medroxyprogesterone Acetate,
pubmed-meshheading:11841143-Obesity,
pubmed-meshheading:11841143-Retrospective Studies,
pubmed-meshheading:11841143-Risk Assessment,
pubmed-meshheading:11841143-Risk Factors,
pubmed-meshheading:11841143-Uterine Hemorrhage
|
pubmed:articleTitle |
Determining risk between Depo-Provera use and increased uterine bleeding in obese and overweight women.
|
pubmed:affiliation |
Department of Family Medicine, The University of Tennessee Health Science Center, Memphis 38104, USA.
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|